Researchers developed a deep learning framework for generating virtual immunostaining on label-free tissue to assess vascular invasion in thyroid cancer.
Key Details
- 1UCLA-led team created a cGAN-based virtual mIHC model for thyroid cancer assessment.
- 2Framework transforms label-free autofluorescence images into virtual stains for ERG, PanCK, and H&E.
- 3Traditional IHC requires one tissue section per stain and is prone to high cost and variability.
- 4The virtual method achieved high concordance with traditional staining, validated by pathologists.
- 5Virtual stains preserve tissue, reduce cost, and streamline diagnostic workflows.
- 6Blind evaluations confirmed accuracy in identifying vascular invasion.
Why It Matters
This innovation significantly improves efficiency, accuracy, and tissue preservation in pathological cancer assessment—a critical step closely intertwined with radiology and imaging AI. Streamlining virtual staining can broadly impact diagnostic workflows in cancer care and potentially extend to other diseases.
Source
EurekAlert
Related News
•EurekAlert
New VIS-Fb Nanobody Probes Transform High-Precision Cellular Imaging
Salk and Einstein researchers have developed visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs) for sharper, multi-color live-cell imaging with minimal background noise.
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.